drugset
drugset / Trial / NCT05435560

Neurochemical Mechanisms of the Awake vs. Anesthetized Brain

NCT05435560 ↗

Phase 0 Unknown 30 enrolled Massachusetts General Hospital Boston University · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The investigators will be studying the sedative drug dexmedetomidine using hybrid PET/fMRI/EEG imaging to better understand the neuropharmacology of anesthesia/artificially induced sleep.

Timeline

Start
2022-04-12
Primary completion
2023-04
Completion
2023-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.6 ug/kg Intravenous

Indications

No indication recorded.